Adims legacy systems operation & maintenance support

Ended Awarded Last action

Contract number
75F40123F19029
Awardee
Awarding agency
Obligated
$1,764,729

Award facts

Contract value 100% obligated
$1,764,729.09 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Westlake, MD 20817, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$1,106
Exercise an Option P00002 $717,433
Exercise an Option P00001 $703,357
Original award $345,045

About this award

International Business Machines Corporation (IBM) was awarded a Blanket Purchase Agreement call valued at $1.76M by the Food and Drug Administration (FDA) for ADIMS Legacy Systems Operation & Maintenance Support, with performance completed by September 23, 2025. This contract represents a task order under the larger Regulatory Review Support Services master BPA, through which the FDA procures operation and maintenance services for legacy systems supporting the agency's regulatory mission. The work will be performed at IBM's facility in Westlake, Maryland. The award utilized a firm fixed-price structure and does not appear to carry a small business set-aside designation, reflecting IBM's position as a large unrestricted contractor. IBM has an extensive history supporting FDA's regulatory review processes through multiple task orders under the BPA vehicle, with previous awards ranging from $201K for training material development to $5.6M for computational science support.

The contract includes subcontracting support from Eclaro International Inc., a minority-owned and small disadvantaged business that provides computer programming and IT services. Eclaro has supported IBM's FDA work through multiple subcontract awards dating back to March 2024, primarily supplying computer programmers and technical specialists. This arrangement allows IBM to leverage small business subcontractors to enhance delivery capabilities while fulfilling socioeconomic program objectives on its FDA engagements, consistent with IBM's broader federal contracting approach of partnering with specialized small business firms to support mission-critical operations across civilian agencies.

Quick answers

Who was awarded contract 75F40123F19029?

75F40123F19029 was awarded to International Business Machines Corporation by Food and Drug Administration (Department of Health and Human Services) on March 22, 2023.

How much is contract 75F40123F19029 worth?

The government has obligated $1,764,729 on 75F40123F19029.

Is contract 75F40123F19029 an order under another contract?

Yes. 75F40123F19029 is a BPA call under GS35F110DA-75F40119A10019, a blanket purchase agreement, on Regulatory Review Support Services.

Was contract 75F40123F19029 competed?

The extent of competition for 75F40123F19029 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award